Australian-Singaporean regenerative medicine company Osteopore (ASX:OSX) has secured market approval for its orthopaedic products in Singapore and Vietnam and has obtained regulatory clearance from Singapore’s Health Sciences Authority and Vietnam’s Department of Medical Equipment and Construction https://app.sharelinktechnologies.com/announcement/asx/9720d721aecbbeb12f2a5f8ebc617816
ATX
0.205
210.6%
ASR
0.001
-50%
AR9
0.22
161.9%
CLG
0.023
-45.2%
IFG
0.011
120%
BCB
0.18
-44.6%
NHE
0.019
72.7%
AMI
0.205
-33.9%
NPM
0.019
72.7%
FCT
0.01
-33.3%
PV1
0.015
66.7%
RDN
0.004
-33.3%
JAV
0.003
50%
SRJ
0.004
-33.3%
PVT
0.009
50%
ICE
0.058
-31%
VR8
0.021
50%
DRE
0.009
-30.8%
SRL
0.73
47.5%
AON
0.005
-28.6%
FMR
0.3
46.3%
RPG
0.044
-26.7%
AHN
0.007
40%
FHS
0.003
-25%
AM5
0.007
40%
LKY
0.062
-22.5%
FDR
0.091
40%
AUG
0.021
-22.2%
EUR
0.061
38.6%
IR1
0.105
-22.2%
VMT
0.085
37.1%
MML
0.021
-22.2%
EVR
0.008
33.3%
ACM
0.06
-22.1%
LU7
0.008
33.3%
CC9
0.054
-21.7%
NAE
0.004
33.3%
JNS
0.15
-21.1%
SIS
0.004
33.3%
WTM
0.26
-20.5%
